Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer's disease
- PMID: 33242587
- DOI: 10.1016/j.nbd.2020.105198
Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer's disease
Abstract
Alzheimer's disease (AD) leads to cerebral accumulation of insoluble amyloid-β plaques causing synaptic dysfunction and neuronal death. Neurons rely on astrocyte-derived glutamine for replenishment of the amino acid neurotransmitter pools. Perturbations of astrocyte glutamine synthesis have been described in AD, but whether this functionally affects neuronal neurotransmitter synthesis is not known. Since the synthesis and recycling of neurotransmitter glutamate and GABA are intimately coupled to cellular metabolism, the aim of this study was to provide a functional investigation of neuronal and astrocytic energy and neurotransmitter metabolism in AD. To achieve this, we incubated acutely isolated cerebral cortical and hippocampal slices from 8-month-old female 5xFAD mice, in the presence of 13C isotopically enriched substrates, with subsequent gas chromatography-mass spectrometry (GC-MS) analysis. A prominent neuronal hypometabolism of [U-13C]glucose was observed in the hippocampal slices of the 5xFAD mice. Investigating astrocyte metabolism, using [1,2-13C]acetate, revealed a marked reduction in glutamine synthesis, which directly hampered neuronal synthesis of GABA. This was supported by an increased metabolism of exogenously supplied [U-13C]glutamine, suggesting a neuronal metabolic compensation of the reduced astrocytic glutamine supply. In contrast, astrocytic metabolism of [U-13C]GABA was reduced, whereas [U-13C]glutamate metabolism was unaffected. Finally, astrocyte de novo synthesis of glutamate and glutamine was hampered, whereas the enzymatic capacity of glutamine synthetase for ammonia fixation was maintained. Collectively, we demonstrate that deficient astrocyte metabolism leads to reduced glutamine synthesis, directly impairing neuronal GABA synthesis in the 5xFAD brain. These findings suggest that astrocyte metabolic dysfunction may be fundamental for the imbalances of synaptic excitation and inhibition in the AD brain.
Keywords: Anaplerosis; GABA metabolism; Glutamate/GABA-glutamine cycle; Glutamine synthetase (GS); Neurons; Pyruvate carboxylase (PC).
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Downregulation of GABA Transporter 3 (GAT3) is Associated with Deficient Oxidative GABA Metabolism in Human Induced Pluripotent Stem Cell-Derived Astrocytes in Alzheimer's Disease.Neurochem Res. 2021 Oct;46(10):2676-2686. doi: 10.1007/s11064-021-03276-3. Epub 2021 Mar 12. Neurochem Res. 2021. PMID: 33710537
-
Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer's disease.Cell Death Dis. 2021 Oct 16;12(11):954. doi: 10.1038/s41419-021-04237-y. Cell Death Dis. 2021. PMID: 34657143 Free PMC article.
-
Astrocyte energy and neurotransmitter metabolism in Alzheimer's disease: Integration of the glutamate/GABA-glutamine cycle.Prog Neurobiol. 2022 Oct;217:102331. doi: 10.1016/j.pneurobio.2022.102331. Epub 2022 Jul 21. Prog Neurobiol. 2022. PMID: 35872221 Review.
-
Specificity of exogenous acetate and glutamate as astrocyte substrates examined in acute brain slices from female mice using methionine sulfoximine (MSO) to inhibit glutamine synthesis.J Neurosci Res. 2017 Nov;95(11):2207-2216. doi: 10.1002/jnr.24038. Epub 2017 Feb 28. J Neurosci Res. 2017. PMID: 28244146
-
The Glutamate/GABA-Glutamine Cycle: Insights, Updates, and Advances.J Neurochem. 2025 Mar;169(3):e70029. doi: 10.1111/jnc.70029. J Neurochem. 2025. PMID: 40066661 Free PMC article. Review.
Cited by
-
Alternative Targets to Fight Alzheimer's Disease: Focus on Astrocytes.Biomolecules. 2021 Apr 19;11(4):600. doi: 10.3390/biom11040600. Biomolecules. 2021. PMID: 33921556 Free PMC article. Review.
-
Single-nucleus transcriptional profiling uncovers the reprogrammed metabolism of astrocytes in Alzheimer's disease.Front Mol Neurosci. 2023 Feb 22;16:1136398. doi: 10.3389/fnmol.2023.1136398. eCollection 2023. Front Mol Neurosci. 2023. PMID: 36910261 Free PMC article.
-
Astrocytes display ultrastructural alterations and heterogeneity in the hippocampus of aged APP-PS1 mice and human post-mortem brain samples.J Neuroinflammation. 2023 Mar 14;20(1):73. doi: 10.1186/s12974-023-02752-7. J Neuroinflammation. 2023. PMID: 36918925 Free PMC article.
-
An Efficient and Cost-Effective Approach to Generate Functional Human Inducible Pluripotent Stem Cell-Derived Astrocytes.Cells. 2023 Sep 26;12(19):2357. doi: 10.3390/cells12192357. Cells. 2023. PMID: 37830571 Free PMC article.
-
Aβ-mediated synaptic glutamate dynamics and calcium dynamics in astrocytes associated with Alzheimer's disease.Cogn Neurodyn. 2024 Dec;18(6):3401-3426. doi: 10.1007/s11571-024-10064-6. Epub 2024 Feb 17. Cogn Neurodyn. 2024. PMID: 39712135
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous